Mariam Mathai, MD | |
7501 Greenway Center Dr # 300, Greenbelt, MD 20770-3514 | |
(301) 474-4679 | |
(301) 474-7182 |
Full Name | Mariam Mathai |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 8 Years |
Location | 7501 Greenway Center Dr # 300, Greenbelt, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346694668 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Retina Group Of Washington, Pllc | 5294702692 | 67 |
The Retina Group Of Washington, Pllc | 5294702692 | 67 |
The Retina Group Of Washington, Pllc | 5294702692 | 67 |
News Archive
Studies indicate that the majority of people with mood and anxiety disorders who receive the most commonly prescribed class of antidepressant medications, Selective Serotonin Reuptake Inhibitors or SSRI's, are not helped by these medications. SSRIs are designed to increase serotonin, a neurotransmitter in the brain that is key to maintenance of mood.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that the independent Data Safety Monitoring Board ("DSMB") recommended that QPI-1002 (I5NP) continue on to the next phase of clinical testing.
Measurement of the protein Dickkopf-1 in serum could be used to diagnose hepatocellular carcinoma, especially early disease, Chinese researchers report.
A newer, less invasive method of heart valve replacement shows promise and may be appropriate for patients who cannot tolerate traditional open heart surgery, but research is needed to understand its potential risks and benefits, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
› Verified 2 days ago
Entity Name | Washington National Eye Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437175684 PECOS PAC ID: 2264424043 Enrollment ID: O20040401000267 |
News Archive
Studies indicate that the majority of people with mood and anxiety disorders who receive the most commonly prescribed class of antidepressant medications, Selective Serotonin Reuptake Inhibitors or SSRI's, are not helped by these medications. SSRIs are designed to increase serotonin, a neurotransmitter in the brain that is key to maintenance of mood.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that the independent Data Safety Monitoring Board ("DSMB") recommended that QPI-1002 (I5NP) continue on to the next phase of clinical testing.
Measurement of the protein Dickkopf-1 in serum could be used to diagnose hepatocellular carcinoma, especially early disease, Chinese researchers report.
A newer, less invasive method of heart valve replacement shows promise and may be appropriate for patients who cannot tolerate traditional open heart surgery, but research is needed to understand its potential risks and benefits, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
› Verified 2 days ago
Entity Name | The Retina Group Of Washington, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225001654 PECOS PAC ID: 5294702692 Enrollment ID: O20040915000226 |
News Archive
Studies indicate that the majority of people with mood and anxiety disorders who receive the most commonly prescribed class of antidepressant medications, Selective Serotonin Reuptake Inhibitors or SSRI's, are not helped by these medications. SSRIs are designed to increase serotonin, a neurotransmitter in the brain that is key to maintenance of mood.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that the independent Data Safety Monitoring Board ("DSMB") recommended that QPI-1002 (I5NP) continue on to the next phase of clinical testing.
Measurement of the protein Dickkopf-1 in serum could be used to diagnose hepatocellular carcinoma, especially early disease, Chinese researchers report.
A newer, less invasive method of heart valve replacement shows promise and may be appropriate for patients who cannot tolerate traditional open heart surgery, but research is needed to understand its potential risks and benefits, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mariam Mathai, MD 7501 Greenway Center Dr # 300, Greenbelt, MD 20770-3514 Ph: (301) 474-4679 | Mariam Mathai, MD 7501 Greenway Center Dr # 300, Greenbelt, MD 20770-3514 Ph: (301) 474-4679 |
News Archive
Studies indicate that the majority of people with mood and anxiety disorders who receive the most commonly prescribed class of antidepressant medications, Selective Serotonin Reuptake Inhibitors or SSRI's, are not helped by these medications. SSRIs are designed to increase serotonin, a neurotransmitter in the brain that is key to maintenance of mood.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that the independent Data Safety Monitoring Board ("DSMB") recommended that QPI-1002 (I5NP) continue on to the next phase of clinical testing.
Measurement of the protein Dickkopf-1 in serum could be used to diagnose hepatocellular carcinoma, especially early disease, Chinese researchers report.
A newer, less invasive method of heart valve replacement shows promise and may be appropriate for patients who cannot tolerate traditional open heart surgery, but research is needed to understand its potential risks and benefits, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
› Verified 2 days ago
Joseph Mekhail, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7500 Greenway Center Dr Ste 300, Greenbelt, MD 20770 Phone: 301-277-4844 | |
Jason Mingyi Huang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr # 300, Greenbelt, MD 20770 Phone: 301-474-4679 | |
Dr. Geoffrey R Kaplan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr, Suite # 300, Greenbelt, MD 20770 Phone: 301-441-4577 Fax: 301-220-0396 | |
Sneha Padidam, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr Ste 300, Greenbelt, MD 20770 Phone: 301-474-4679 Fax: 301-474-7182 | |
Mr. Stephen Melvyn Solomon, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7500 Hanover Pkwy, Ste 101b, Greenbelt, MD 20770 Phone: 301-982-4565 Fax: 301-982-4252 | |
Mr. Jonathan David Solomon, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7500 Hanover Pkwy, Ste 101b, Greenbelt, MD 20770 Phone: 301-982-4565 Fax: 301-982-4252 |